281 related articles for article (PubMed ID: 36949765)
21. Identification of potential drug-related problems in the elderly: the role of the community pharmacist.
Vinks TH; de Koning FH; de Lange TM; Egberts TC
Pharm World Sci; 2006 Feb; 28(1):33-8. PubMed ID: 16703267
[TBL] [Abstract][Full Text] [Related]
22. Effects of a three party healthcare network on the incidence levels of drug related problems.
Fiß T; Meinke-Franze C; van den Berg N; Hoffmann W
Int J Clin Pharm; 2013 Oct; 35(5):763-71. PubMed ID: 23851929
[TBL] [Abstract][Full Text] [Related]
23. A multicenter quality improvement initiative on the impact of pharmacists' postdischarge follow-up to reduce medication-related acute care episodes.
Noh L; Heimerl K; Shane R
Am J Health Syst Pharm; 2020 Jun; 77(12):938-942. PubMed ID: 31960043
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.
Amador-Fernández N; Escaith M; Simi E; Quintana-Bárcena P; Berger J
PLoS One; 2023; 18(10):e0292037. PubMed ID: 37847695
[TBL] [Abstract][Full Text] [Related]
25. Pharmacist-led medication reviews in pre-dialysis and dialysis patients.
van Berlo-van de Laar IRF; Sluiter HE; Riet EV'; Taxis K; Jansman FGA
Res Social Adm Pharm; 2020 Dec; 16(12):1718-1723. PubMed ID: 32111533
[TBL] [Abstract][Full Text] [Related]
26. Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities.
Lexow M; Wernecke K; Sultzer R; Bertsche T; Schiek S
BMC Geriatr; 2022 Apr; 22(1):307. PubMed ID: 35397527
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.
Ertuna E; Arun MZ; Ay S; Koçak FÖK; Gökdemir B; İspirli G
Clin Interv Aging; 2019; 14():587-600. PubMed ID: 30962679
[TBL] [Abstract][Full Text] [Related]
28. Pharmacists in general practice: a focus on drug-related problems.
Benson H; Lucas C; Kmet W; Benrimoj SI; Williams K
Int J Clin Pharm; 2018 Jun; 40(3):566-572. PubMed ID: 29542035
[TBL] [Abstract][Full Text] [Related]
29. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
30. Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand.
Braund R; Coulter CV; Bodington AJ; Giles LM; Greig AM; Heaslip LJ; Marshall BJ
Int J Clin Pharm; 2014 Jun; 36(3):498-502. PubMed ID: 24700340
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation.
Hohn N; Langer S; Kalder J; Jacobs MJ; Marx G; Eisert A
J Cardiovasc Surg (Torino); 2014 Apr; 55(2 Suppl 1):175-81. PubMed ID: 24796911
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Pharmacist Medication Review Service in an Outpatient Heart Failure Clinic.
Yates L; Valente M; Wadsworth C
J Pharm Pract; 2020 Dec; 33(6):820-826. PubMed ID: 31057060
[TBL] [Abstract][Full Text] [Related]
33. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
[TBL] [Abstract][Full Text] [Related]
34. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
35. The contribution of patient interviews to the identification of drug-related problems in home medication review.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2012 Dec; 37(6):674-80. PubMed ID: 22861493
[TBL] [Abstract][Full Text] [Related]
36. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
37. Pharmacist's Impact on Medication Adherence and Drug-Related Problems in Patients with Epilepsy.
Özdağ E; Fırat O; Çoban Taşkın A; Uludağ İF; Şener U; Demirkan K
Turk J Pharm Sci; 2024 Jan; 20(6):361-367. PubMed ID: 38254332
[TBL] [Abstract][Full Text] [Related]
38. Detection and resolution of drug-related problems at hospital discharge focusing on information availability - a retrospective analysis.
Imfeld-Isenegger TL; Studer H; Ceppi MG; Rosen C; Bodmer M; Beeler PE; Boeni F; Häring AP; Hersberger KE; Lampert ML
Z Evid Fortbild Qual Gesundhwes; 2021 Nov; 166():18-26. PubMed ID: 34538579
[TBL] [Abstract][Full Text] [Related]
39. Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs.
Bremer S; Henjum S; Sæther EM; Hovland R
Res Social Adm Pharm; 2022 Nov; 18(11):3939-3947. PubMed ID: 35750567
[TBL] [Abstract][Full Text] [Related]
40. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions.
Zhang S; Zhang GB; Huang P; Ren Y; Lin B; Shao YF; Ye XL
BMC Geriatr; 2023 Dec; 23(1):849. PubMed ID: 38093184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
